Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data
Sign Up to like & getrecommendations! Published in 2017 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-017-3681-2
Abstract: Dear Editor: We would to address several challenges that have arisen from the study by Chatziralli et al. [1], which can be specifically summarized below. Several relevant data are missing from the study (Table 1).… read more here.
Keywords: study; final results; etdrs letters; aflibercept ... See more keywords
Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-20525-8
Abstract: Macular edema due to neovascular age-related macular degeneration, diabetes or retinal vein occlusion can cause central vision loss. Intravitreal treatment with antibody-based biopharmaceutical compounds designed to neutralize vascular endothelial growth factor (VEGF) has proven to… read more here.
Keywords: compounding aflibercept; vegf; aflibercept prefilled; aflibercept ... See more keywords